Invitae Receives Court Approval for Sale to Labcorp

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical genetics company, announce that the United States Bankruptcy Court has approved the previously announced bid by Labcorp to acquire assets of Invitae. “As a leading medical genetics company, Invitae has advanced genomics-based testing solutions across its network,” said Mark Schroeder, Executive Vice President and President of Diagnostics Laboratories and Chief Operations Officer of Labcorp. “Invitae will complement our business and advance our leadership in genetic screening, diagnostics and specialty testing. This supports our goal to provide best-in-class resources and health insights for patients and physicians.”

Read the full article: Invitae Receives Court Approval for Sale to Labcorp //

Source: https://www.prnewswire.com/news-releases/invitae-receives-court-approval-for-sale-to-labcorp-302138770.html

Leave a Comment

Your email address will not be published.

Scroll to Top